ZA946253B - Phenoxyphenyl cyclopenteyl hydroxyureas - Google Patents

Phenoxyphenyl cyclopenteyl hydroxyureas

Info

Publication number
ZA946253B
ZA946253B ZA946253A ZA946253A ZA946253B ZA 946253 B ZA946253 B ZA 946253B ZA 946253 A ZA946253 A ZA 946253A ZA 946253 A ZA946253 A ZA 946253A ZA 946253 B ZA946253 B ZA 946253B
Authority
ZA
South Africa
Prior art keywords
pct
date
above compounds
cyclopenteyl
hydroxyureas
Prior art date
Application number
ZA946253A
Other languages
English (en)
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA946253B publication Critical patent/ZA946253B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Hydrogenated Pyridines (AREA)
ZA946253A 1993-08-19 1994-08-18 Phenoxyphenyl cyclopenteyl hydroxyureas ZA946253B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19

Publications (1)

Publication Number Publication Date
ZA946253B true ZA946253B (en) 1996-02-19

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946253A ZA946253B (en) 1993-08-19 1994-08-18 Phenoxyphenyl cyclopenteyl hydroxyureas

Country Status (27)

Country Link
US (1) US5792882A (xx)
EP (1) EP0720598B1 (xx)
JP (1) JP2794343B2 (xx)
KR (1) KR0170623B1 (xx)
CN (1) CN1077568C (xx)
AT (1) ATE171939T1 (xx)
AU (1) AU674776B2 (xx)
BR (1) BR9407314A (xx)
CA (1) CA2169066C (xx)
CO (1) CO4230229A1 (xx)
CZ (1) CZ288358B6 (xx)
DE (1) DE69413831T2 (xx)
DK (1) DK0720598T3 (xx)
EC (1) ECSP941144A (xx)
EG (1) EG20530A (xx)
ES (1) ES2121218T3 (xx)
FI (1) FI114466B (xx)
IL (1) IL110628A (xx)
MY (1) MY111140A (xx)
NO (1) NO305595B1 (xx)
NZ (1) NZ269849A (xx)
PE (1) PE57194A1 (xx)
PL (1) PL176223B1 (xx)
RU (1) RU2125987C1 (xx)
TW (2) TW418089B (xx)
WO (1) WO1995005360A1 (xx)
ZA (1) ZA946253B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9606635A (es) * 1994-06-27 1997-12-31 Cytomed Inc Compuestos y metodos para el tratamiento de desordenes cardiovasculares, inflamatorios e inmunes.
ATE184272T1 (de) * 1994-11-10 1999-09-15 Pfizer Aryloxycycloalkenyl- und aryloxyiminocycloalkenyl-hydroxyharnstoffe mit 5-lipoxygenase inhibierender wirkung
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1745774A3 (en) 1997-08-11 2007-04-11 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
US8013187B2 (en) * 2004-12-02 2011-09-06 Amorepacific Corporation 2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α
WO2009072807A2 (en) * 2007-12-03 2009-06-11 Amorepacific Corporation Pharmaceutical composition for preventing or treating fat metabolism-related diseases containing 2-cyclopentene-1-one oxime derivatives
HUE027598T2 (en) 2009-04-03 2016-10-28 Hoffmann La Roche Propane-1-sulfonic acid {3- [5- (4-chlorophenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluorophenyl} amide compositions and their uses
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
DE69004119T2 (de) * 1989-02-03 1994-03-24 Wellcome Found Entzündungshemmende Arylderivate.
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
NO960631L (no) 1996-02-16
DK0720598T3 (da) 1999-06-21
EP0720598B1 (en) 1998-10-07
EP0720598A1 (en) 1996-07-10
WO1995005360A1 (en) 1995-02-23
BR9407314A (pt) 1996-04-16
US5792882A (en) 1998-08-11
TW448144B (en) 2001-08-01
CA2169066A1 (en) 1995-02-23
AU7350994A (en) 1995-03-14
EG20530A (en) 1999-07-31
DE69413831D1 (de) 1998-11-12
NZ269849A (en) 1997-10-24
DE69413831T2 (de) 1999-02-25
CA2169066C (en) 1999-06-22
PE57194A1 (es) 1995-02-07
IL110628A (en) 1998-12-27
TW418089B (en) 2001-01-11
FI943799A (fi) 1995-02-20
JPH08511031A (ja) 1996-11-19
KR0170623B1 (ko) 1999-03-30
NO960631D0 (no) 1996-02-16
MY111140A (en) 1999-08-30
ATE171939T1 (de) 1998-10-15
FI114466B (fi) 2004-10-29
NO305595B1 (no) 1999-06-28
CZ288358B6 (en) 2001-05-16
PL313037A1 (en) 1996-05-27
RU2125987C1 (ru) 1999-02-10
CZ48396A3 (en) 1996-07-17
ECSP941144A (es) 1995-02-27
CN1129440A (zh) 1996-08-21
CN1077568C (zh) 2002-01-09
CO4230229A1 (es) 1995-10-19
AU674776B2 (en) 1997-01-09
JP2794343B2 (ja) 1998-09-03
ES2121218T3 (es) 1998-11-16
IL110628A0 (en) 1994-11-11
FI943799A0 (fi) 1994-08-18
PL176223B1 (pl) 1999-05-31
KR960703845A (ko) 1996-08-31

Similar Documents

Publication Publication Date Title
DE69522947D1 (en) Phenylxanthin-derivate
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
AU3345595A (en) 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
ZA946253B (en) Phenoxyphenyl cyclopenteyl hydroxyureas
BR9507677A (pt) Composto composição farmacéutica processo para a profilaxia ou para o tratamento de condições associadas à inflamação à artrite ou à dor em um mamifero uso do composto processo para a preparação do composto e novo intermediário
IL113706A (en) N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger